MicroRNA Profiling

MicroRNA Profiling

MicroRNAs, or miRNAs, are small RNAs that regulate gene expression after transcription has taken place. This occurs in both healthy physiological states and diseased states in many organisms. Due to the range of processes they help regulate, miRNAs can provide valuable biomarkers in disease contexts; this is why profiling miRNA expression is a growing field of study.

microRNA Discovery & Profiling

The Interestin miRNA

miRNAs are short, non-coding RNA fragments that help regulate gene expression. After transcription of the original DNA, the messenger RNA (mRNA) is released and the miRNA can bind to it. This binding promotes degradation of the mRNA or inhibition of translation, thereby hindering protein formation. The miRNAs are few in number compared to mRNA targets, with roughly 1 miRNA for every 30 mRNA. However, these few miRNAs can regulate many mRNAs and therefore  have a profound effect on expression.

Given that one miRNA can potentially regulate hundreds of mRNA, it has been inferred that the expression pattern of those hundreds of mRNA can be captured in one single miRNA. This wealth of biological information is appealing to researchers in fields such as developmental biology, tissue differentiation, and disease. miRNA profiling involves the analysis of expression of miRNAs ranging from species level to smaller groups of biological interest.

David Bartel (Whitehead Institute/MIT/HHMI) Part 1: MicroRNAs: Introduction to MicroRNAs

Applications of Profiling

miRNA can regulate which mRNAs get translated into proteins, and therefore can suppress inappropriate gene expression. In developmental biology, the comparison of miRNA profiles can help show which miRNAs are involved in certain developmental processes. Such research has shown that miRNA profiles, or expression patters, can be specific to certain cell types. In addition, miRNAs can halt developmental transitions and help maintain the cell state once it has differentiated. This has  led researchers to believe miRNA can have valuable applications in understanding stem cells.

In disease contexts, miRNAs are being explored as sources of biomarkers of certain diseases. miRNA profiles of healthy and diseased tissues are compared to identify the disease biomarkers and potential therapeutic targets. This tactic has been employed in cancer, autoimmune, and neurological diseases.

In  particular,  abnormal miRNAs are of interest both therapeutically and in studying tumor progression in cancer. The underlying cause for the differences in miRNA expression between healthy and diseased tissues can be due to DNA point mutations, epigenetic variation, or chromosomal changes to miRNA genes. In cancer, miRNA profiling has also been used to clinically diagnose the cancer origin when other identification is difficult. miRNA has even been employed in forensics for similar reasons, as miRNA profiles can help distinguish the types of body fluid found in crime scenes.

Methods of miRNA Profiling

miRNA profiling can be done using a range of methods, such as quantitative reverse transcription polymerase chain reaction (qRT-PCR), miRNA microarray, and RNA sequencing. qRT-PCR involves reverse transcription of the miRNA into cDNA, and subsequent sequencing of the product.

This method is commonly applied to other genetic study and is therefore appealing to laboratories already familiar with the method. To profile miRNA using qRT-PCR, several miRNAs are analyzed in parallel under the same reaction conditions. However, miRNAs can differ drastically in their optimal conditions which means analyzing miRNAs in parallel can be difficult. To overcome this, researchers may use locked nucleic acids (LNAs) in the primers themselves.

Microarrays also analyze several miRNAs in parallel during profiling. In the microarray, miRNAs are fluorescently tagged. DNA-based capture probes are then used to hybridize the tagged miRNA. These probes may or may not contain LNAs, just like in qRT-PCR. The array is then scanned, and the fluorescence is quantified to profile the miRNA. Microarrays allow many more samples to be profiled in tandem, however  this method is usually more expensive.

A more novel approach to miRNA profiling is next-generation sequencing. RNA sequencing (RNA-seq) is one such method and is often considered the most powerful new technique for miRNA profiling. Like qRT-PCR, in RNA-seq the sample undergoes reverse transcription to generate a cDNA library. Adaptors are inserted on to the ends of the cDNA strands and the samples are amplified using PCR. The raw sequence data is analyzed using bioinformatics to reveal known miRNAs. Prediction of new miRNAs is also possible.

Further Reading

Last Updated: Feb 26, 2019

Sara Ryding

Written by

Sara Ryding

Sara is a passionate life sciences writer who specializes in zoology and ornithology. She is currently completing a Ph.D. at Deakin University in Australia which focuses on how the beaks of birds change with global warming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ryding, Sara. (2019, February 26). MicroRNA Profiling. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/life-sciences/MicroRNA-Profiling.aspx.

  • MLA

    Ryding, Sara. "MicroRNA Profiling". News-Medical. 21 November 2024. <https://www.news-medical.net/life-sciences/MicroRNA-Profiling.aspx>.

  • Chicago

    Ryding, Sara. "MicroRNA Profiling". News-Medical. https://www.news-medical.net/life-sciences/MicroRNA-Profiling.aspx. (accessed November 21, 2024).

  • Harvard

    Ryding, Sara. 2019. MicroRNA Profiling. News-Medical, viewed 21 November 2024, https://www.news-medical.net/life-sciences/MicroRNA-Profiling.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.